# FDA recall D-0104-2021

> **Jubilant Cadista Pharmaceuticals, Inc.** · Class II · drug recall initiated 2020-11-06.

## Product

clomiPRAMINE Hydrochloride Capsules USP, 50 mg, 30-count bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD  NDC 59746-711-30

## Reason for recall

Failed Tablet/Capsule Specification

## Distribution

Product was distributed nationwide.

## Key facts

- **Recall number:** D-0104-2021
- **Recalling firm:** Jubilant Cadista Pharmaceuticals, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-11-06
- **Report date:** 2020-12-02
- **Termination date:** 2022-03-23

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Salisbury, MD, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0104-2021

## Citation

> AI Analytics. FDA recall D-0104-2021. Retrieved 2026-07-08 from https://api.ai-analytics.org/recall/D-0104-2021. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*